Researchers at Purdue University's Weldon School of Biomedical Engineering are investigating how ultrasound can be used to study abdominal aortic aneurysms, the 13th leading cause of death in the U.S.
Philips Abdominal Aortic Aneurysm (AAA) Model helps increase diagnostic confidence and improved patient experience compared to current standard of care Amsterdam, the Netherlands – Royal Philips (NYSE ...
Using contrast enhanced ultrasound is an effective way of monitoring patients undergoing endovascular repair for abdominal aortic aneurysms without any noninvasive tests, a study published in the ...
Ultrasound demonstrated a strong correlation and agreement with CT in assessing the diameter of the ascending aorta in patients with giant cell arteritis (GCA), supporting its use as an effective ...
BURLINGTON, Mass. & NEW YORK, August 05, 2025--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive ...
In the current issue of Cardiovascular Innovations and Applications, Niya Mileva, Medical University of Sofia, Sofia, Bulgaria and other researchers from Poland and Italy present a case study of ...
In the current issue of Cardiovascular Innovations and Applications (Volume 2, Number 4, 2018, pp 447-449(3); DOI: https:/ / doi. org/ 10. 15212/ CVIA. 2017. 0028, Niya Mileva, Medical University of ...
French researchers have developed a noninvasive ultrasound therapy to treat certain patients with aortic stenosis. In a small study published in The Lancet, they demonstrated its effectiveness.
Purdue University researchers are using ultrasound images like this one to study abdominal aortic aneurysms, a potentially fatal condition that is the 13th leading cause of death in the United States.
PLAINFIELD TOWNSHIP -- Free ultrasound screenings will be offered Saturday for a potentially deadly health condition that few people know about -- abdominal aortic aneurysm. A coalition of doctors, ...
A new Non-Invasive Ultrasound Therapy (NIUT) for the treatment of cardio-valvular diseases such as aortic stenosis has been developed by Cardiawave (France). A First-in-Man clinical trial in 10 ...